Earnings History Data for Atea Pharmaceuticals (AVIR) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Atea Pharmaceuticals

Atea Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on discovering, developing and commercializing antiviral therapeutics to improve the lives of patients suffering from life-threatening viral infections. Atea Pharmaceuticals Inc. is based in BOSTON.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
06-03-2025	AH		AVIR	Atea Pharmaceuticals	245.00	-0.40	-0.35	0.00	Atea Pharmaceuticals GAAP EPS of -$0.40 misses by $0.03 [3/6/2025 4:27 PM]	3.01	0.01 (0.33%)	2.96	-0.04 (-1.33%)	2.75 - 4.18	332,901	320,000	590
Atea Pharmaceuticals GAAP EPS of -$0.40 misses by $0.03 [3/6/2025 4:27 PM] Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update [2025-03-06 04:05PM] Atea Pharmaceuticals Inc (AVIR) Q4 2024 Earnings Call Highlights: Strategic Moves and Promising ... [2025-03-07 02:17AM] Q4 2024 Atea Pharmaceuticals Inc Earnings Call [2025-03-07 12:46PM]
07-11-2024	AH		AVIR	Atea Pharmaceuticals, Inc.	283.66	-0.37	-0.50	-0.40	Atea Pharmaceuticals reports Q3 results [11/7/2024 5:42 PM]	3.50	0.06 (1.89%)	3.35	-0.09 (-2.62%)	2.77 - 4.60	115,282	160,000	181
Atea Pharmaceuticals files for $500M mixed securities shelf [11/7/2024 5:45 PM] Atea Pharmaceuticals reports Q3 results [11/7/2024 5:42 PM] Atea Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update [2024-11-07 04:05PM]
07-08-2024	AH		AVIR	Atea Pharmaceuticals, Inc.	290.57	-0.48	-0.76	-0.34	Atea Pharmaceuticals GAAP EPS of -$0.48 beats by $0.29 [8/7/2024 5:35 PM]	3.47	0.20 (6.12%)	3.27	0.0 (0.00%)	2.77 - 4.60	172,410	210,000	3,346
Atea Pharmaceuticals GAAP EPS of -$0.48 beats by $0.29 [8/7/2024 5:35 PM]
14-05-2024	AH		AVIR	Atea Pharmaceuticals, Inc.	327.40	-0.75	-0.61	-0.43	Atea Pharmaceuticals GAAP EPS of -$0.75 misses by $0.14 [5/14/2024 4:16 PM]	3.71	-0.25 (-6.44%)	3.96	0.0 (0.00%)	2.77 - 5.19	628,267	210,000	3,239
Atea Pharmaceuticals GAAP EPS of -$0.75 misses by $0.14 [5/14/2024 4:16 PM]
28-02-2024	AH		AVIR	Atea Pharmaceuticals	350.00	-0.47	-0.44	0.00	Atea Pharmaceuticals GAAP EPS of -$0.47 beats by $0.03 [2/28/2024 4:28 PM]	4.32	-0.05 (-1.14%)	4.40	0.03 (0.69%)	2.77 - 5.19	481,077	380,000	10,941
Atea Pharmaceuticals GAAP EPS of -$0.47 beats by $0.03 [2/28/2024 4:28 PM]
08-11-2023	AH		AVIR	Atea Pharmaceuticals, Inc.	270.21	-0.40	-0.46	-0.10	Atea Pharmaceuticals GAAP EPS of -$0.40 [11/8/2023 4:22 PM]	3.00	-0.29 (-8.97%)	3.25	-0.04 (-1.22%)	2.85 - 5.32	460,465	430,000	3,513
Atea Pharmaceuticals GAAP EPS of -$0.40 [11/8/2023 4:22 PM]
08-08-2023	AH		AVIR	Atea Pharmaceuticals, Inc.	289.40	-0.34	-0.47	-0.38	Atea Pharmaceuticals GAAP EPS of -$0.34 beats by $0.15 [8/8/2023 5:49 PM]	3.52	0.11 (3.37%)	3.41	0.0 (0.00%)	2.94 - 9.79	313,179	250,000	3,861
Atea Pharmaceuticals GAAP EPS of -$0.34 beats by $0.15 [8/8/2023 5:49 PM]
08-05-2023	AH	4:05 PM ET (May 8)	AVIR	Atea Pharmaceuticals, Inc.	277.53	-0.43	-0.51	-0.51	Atea Pharmaceuticals GAAP EPS of -$0.43 beats by $0.07 [5/8/2023 4:13 PM]	3.31	-0.09 (-2.65%)	3.40	0.0 (0.00%)	2.94 - 9.79	622,693	540,000	6,241
Atea Pharmaceuticals GAAP EPS of -$0.43 beats by $0.07 [5/8/2023 4:13 PM]
28-02-2023	AH	4:05 PM ET (Feb 28)	AVIR	Atea Pharmaceuticals, Inc.	332.32	-0.41	-0.45	1.34	Atea Pharmaceuticals GAAP EPS of -$0.41 beats by $0.04 [2/28/2023 4:44 PM]	3.23	-0.31 (-8.62%)	3.49	-0.05 (-1.41%)	3.22 - 9.79	515,795	380,000	545
Atea Pharmaceuticals GAAP EPS of -$0.41 beats by $0.04 [2/28/2023 4:44 PM]
07-11-2022	AH	4:05 PM ET (Nov 7)	AVIR	Atea Pharmaceuticals, Inc.	503.71	-0.10	-0.44	-0.34	Atea Pharmaceuticals GAAP EPS of -$0.10 beats by $0.34 [11/7/2022 4:10 PM]	5.30	-0.57 (-9.71%)	6.00	0.13 (2.21%)	5.04 - 11.72	985,866	470,000	10,598
Atea Pharmaceuticals Q3 2022 Earnings Preview [11/7/2022 12:38 AM] Atea Pharmaceuticals GAAP EPS of -$0.10 beats by $0.34 [11/7/2022 4:10 PM] Why Atea Pharmaceuticals (AVIR) Might Surprise This Earnings Season [Nov-04-22 08:36AM] Atea Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update [Nov-07-22 04:05PM]
08-08-2022	AH	4:05 PM ET (Aug 8)	AVIR	Atea Pharmaceuticals, Inc.	666.06	-0.38	-0.52	0.02	Atea Pharmaceuticals GAAP EPS of -$0.38 beats by $0.14 [8/8/2022 4:37 PM]	8.48	-0.11 (-1.28%)	8.81	0.22 (2.56%)	5.31 - 46.91	782,904	330,000	644
Atea Pharmaceuticals Q2 2022 Earnings Preview [8/8/2022 3:26 AM] Atea Pharmaceuticals Q2 2022 Earnings Preview [8/8/2022 3:03 AM] Atea Pharmaceuticals GAAP EPS of -$0.38 beats by $0.14 [8/8/2022 4:37 PM] Atea Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update [Aug-08-22 04:05PM]
10-05-2022	PM	0:00 AM ET (May 10)	AVIR	Atea Pharmaceuticals, Inc.	459.58	-0.51	-0.58	0.34	Atea Pharmaceuticals GAAP EPS of -$0.51 beats by $0.05 [5/10/2022 6:38 AM]	5.78	0.45 (8.44%)	5.55	0.22 (4.13%)	5.31 - 46.91	927,596	825,688	15,068
Atea Pharmaceuticals GAAP EPS of -$0.51 beats by $0.05 [5/10/2022 6:38 AM] Atea Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update [May-10-22 06:30AM]
28-02-2022	AH	4:00 PM ET (Feb 28)	AVIR	Atea Pharmaceuticals, Inc.	516.90	1.34	0.32	0.00	Atea Pharmaceuticals GAAP EPS of $1.34 beats by $0.96, revenue of $192.2M beats by $81.11M [2/28/2022 4:25 PM]	6.46	0.12 (1.81%)	6.88	0.54 (8.52%)	5.50 - 79.49	2,554,993	1,030,000	70,016
Atea Pharmaceuticals GAAP EPS of $1.34 beats by $0.96, revenue of $192.2M beats by $81.11M [2/28/2022 4:25 PM] Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update [Feb-28-22 04:05PM] Atea Pharma stock jumps as earnings rise, potential COVID-19 therapy advances [Feb-28-22 06:40PM] Zoom Reports Slowing Growth, but This Stock Is Monday's Real After-Hours Winner [Feb-28-22 07:19PM] Atea Pharmaceuticals, Inc. (AVIR) Q4 2021 Earnings Call Transcript [Feb-28-22 10:00PM]
11-11-2021	AH	4:05 PM ET (Nov 11)	AVIR	Atea Pharmaceuticals, Inc.	903.92	-0.34	-0.05	-1.74	Atea Pharmaceuticals EPS misses by $0.17, misses on revenue [11/11/2021 4:39 PM]	11.34	0.70 (6.58%)	11.10	0.46 (4.32%)	10.28 - 94.17	2,493,938	1,810,000	20,107
Atea Pharmaceuticals EPS misses by $0.17, misses on revenue [11/11/2021 4:39 PM] Atea Pharmaceuticals Provides Clinical and Corporate Update and Reports Third Quarter 2021 Financial Results [Nov-11-21 04:01PM] Atea Pharmaceuticals Inc (AVIR) Q3 2021 Earnings Call Transcript [Nov-12-21 05:00AM]
12-08-2021	AH	4:05 PM ET (Aug 12)	AVIR	Atea Pharmaceuticals, Inc.	2,720	0.02	0.01	0.00	Atea Pharmaceuticals EPS beats by $0.02, beats on revenue [8/12/2021 4:25 PM]	27.84	-3.27 (-10.51%)	30.60	-0.51 (-1.64%)	18.72 - 94.17	1,729,304	1,060,000	11,421
Atea Pharmaceuticals EPS beats by $0.02, beats on revenue [8/12/2021 4:25 PM] Atea Pharmaceuticals Provides Clinical and Corporate Update and Reports Second Quarter 2021 Financial Results [Aug-12-21 04:05PM] Atea Pharmaceuticals Inc (AVIR) Q2 2021 Earnings Call Transcript [Aug-13-21 12:00AM] Read This Before Judging Atea Pharmaceuticals, Inc.'s (NASDAQ:AVIR) ROE [Aug-13-21 01:37AM]
13-05-2021	AH	7:35 PM ET (May 13)	AVIR	Atea Pharmaceuticals, Inc.	1,710	0.34	-0.05	0.00	Atea Pharmaceuticals EPS beats by $0.39, beats on revenue [5/13/2021 4:51 PM]	22.96	3.74 (19.45%)	20.89	1.67 (8.69%)	18.72 - 94.17	1,555,160	1,070,000	5,463
Atea Pharmaceuticals EPS beats by $0.39, beats on revenue [5/13/2021 4:51 PM] Atea regains as Q1 results bring clarity to late-stage trial for COVID-19 therapy [5/14/2021 12:42 PM] Atea Pharmaceuticals (AVIR) Enters Oversold Territory [May-13-21 06:24AM] Atea Pharmaceuticals Inc to Host Earnings Call [May-13-21 02:30PM] Atea Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update [May-13-21 04:05PM]
30-03-2021	AH	7:35 PM ET (Mar 30)	AVIR	Atea Pharmaceuticals, Inc.	4,970	N/A	0.25	0.00	Atea Pharmaceuticals EPS beats by $0.94 [3/30/2021 5:01 PM]	61.58	5.36 (9.52%)	56.25	0.02 (0.04%)	24.15 - 94.17	444,642	380,000	850
Atea Pharmaceuticals EPS beats by $0.94 [3/30/2021 5:01 PM] Atea Pharmaceuticals Inc to Host Earnings Call [Mar-30-21 02:30PM] Atea Pharmaceuticals Reports Full Year 2020 Financial Results and Provides Corporate Update [Mar-30-21 04:01PM] Biota Pharmaceuticals (AVIR) Q4 2020 Earnings Call Transcript [Mar-31-21 02:00AM] Who Has Been Buying Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Shares? [Mar-31-21 01:54AM]